sglt2 vs glp 1 vs dpp4 inhibitors GLP-1 receptor agonists in T2D Recommendations for SGLT2i versus GLP-1

In June, a European medical safety committee noted that Wegovy and Ozempic have been linked in very rare cases to the eye condition, Reuters reported, which led Novo Nordisk to update its European labels for Wegovy and Ozempic to state that semaglutide, their active ingredient, may cause NAION in up to 1 in 10,000 patients

The most common effects are gastrointestinal nausea, reduced appetite or digestive changes and are usually managed with careful dose titration

Watch What You Eat and Drink: Acidic and sugary foods can damage enamel, especially when youre already dealing with reduced saliva or acid exposure

doi: 10.2337/dc24-S009 14 DruckerDJ